1. Hepatopulmonay syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod;Baweja;J Hepatol,2023
2. Fingolimod, a sphingosine-1-phosphate agonist for the treatment of hepatopulmonary syndrome: queries and concerns;Ashraf;J Hepatol,2023
3. Potential clinical targets in hepatopulmonary syndrome: lessons from experimental models;Raevens;Hepatology,2018
4. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome;Fallon;AmJPhysiol,1997
5. Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice;Raevens;Hepatology,2017